Titan Securities
43.99
+0.01(+0.02%)
Market Cap₹110.03 Cr
PE Ratio8.83
Company Performance:
1D+0.02%
1M-4.72%
6M+11.79%
1Y+30.15%
5Y+325.44%
View Company Insightsright
More news about Titan Securities
12Feb 26
Titan Securities Reports Mixed Q3FY26 Results with Standalone Profit Decline
Titan Securities Limited reported mixed Q3FY26 results with standalone net profit declining 46.93% to ₹37.88 lakhs from ₹71.37 lakhs in Q3FY25. Revenue from operations dropped significantly to ₹101.25 lakhs from ₹334.90 lakhs year-on-year. However, consolidated performance remained strong with net profit rising 44.37% to ₹367.18 lakhs, primarily driven by ₹329.30 lakhs contribution from associate companies. The Board approved these results on February 12, 2026.
 no imag found
31Jan 26
Titan Securities Limited Board Meeting Scheduled for February 12, 2026 to Consider Q3FY26 Unaudited Financial Results
Titan Securities Limited has scheduled a board meeting for February 12, 2026, to consider Q3FY26 unaudited standalone and consolidated financial results for the quarter ended December 31, 2025. The meeting will be held at the company's Delhi office in compliance with SEBI regulations. Trading window restrictions continue for directors, promoters, employees, and their relatives until 48 hours after results declaration.
 no imag found
11Nov 25
Titan Securities Limited Reports Q2 FY2026 Financial Results
Titan Securities Limited announced unaudited financial results for Q2 and H1 FY2026 ending September 30, 2025. The consolidated net profit after tax and total comprehensive income stood at Rs. 320.03 lakhs. Results include associates Titan Biotech Limited and Peptech Biosciences Limited. A N S K & Associates conducted an independent review, finding compliance with Ind AS 34 and no material misstatements. The company adhered to SEBI regulations for result submission and disclosure.
 no imag found
25Aug 25
Titan Securities Approves Re-appointment of Manju Singla as Managing Director
Titan Securities Limited has announced the re-appointment of Mrs. Manju Singla as Managing Director for a five-year term starting October 1, 2025, subject to shareholder approval at the upcoming 33rd AGM. The re-appointment is without remuneration, and Mrs. Singla will not be liable to retire by rotation. She holds 34,43,128 equity shares in the company and is the spouse of Director Mr. Suresh Chand Singla. The 33rd AGM is scheduled for September 26, 2025, via video conference.
 no imag found
19Aug 25
Titan Securities' Statutory Auditor ANSK & Associates Resigns
Titan Securities Limited announced the resignation of its statutory auditor, M/s. ANSK & Associates, Chartered Accountants, effective August 19, 2025. The company stated there were no concerns raised by the auditor regarding management. Titan Securities will appoint new statutory auditors to fill the casual vacancy, with details to be provided in due course. The resignation complies with SEBI regulations, and no material reasons were given for the departure.
 no imag found
13Aug 25
Titan Securities Limited Reports Q1 Results and Announces Key Appointments
Titan Securities Limited's Board approved Q1 financial results, with associates Titan Biotech and Peptech Biosciences contributing Rs. 274.16 lacs to net profit. The company appointed Mr. Amit Anand as Secretarial Auditor for five years, PGM & Associates as Internal Auditor for two years, and Mr. Pankaj Kumar Gupta as Scrutinizer for the 33rd AGM. These appointments aim to enhance corporate governance and compliance.
 no imag found
Titan Securities
43.99
+0.01
(+0.02%)
1 Year Returns:+30.15%
Industry Peers
Bajaj Finance
869.10
(-1.46%)
Shriram Finance
897.85
(-1.52%)
Muthoot Finance
3,172.80
(-2.74%)
Cholamandalam Investment
1,455.70
(-1.83%)
SBI Cards
596.10
(-1.55%)
Sundaram Finance
4,178.40
(-1.69%)
Authum Inv & Infr
445.95
(-1.70%)
Poonawalla Fincorp
392.45
(-1.34%)